You are in: eMedicine Specialties > Emergency Medicine > TRAUMA AND ORTHOPEDICS Acromioclavicular InjuryArticle Last Updated: Apr 1, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Moira Davenport, MD, Attending Physician, Departments of Emergency Medicine and Orthopedic Surgery, Allegheny General Hospital Moira Davenport is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine Coauthor(s): Joseph Kim, MD, Chairman, Department of Emergency Medicine, Western Medical Center; Clinical Instructor, University of California at Irvine Editors: Roy Alson, MD, PhD, FACEP, FAAEM, Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine; Medical Director, Forsyth County EMS; Deputy Medical Advisor, North Carolina Office of EMS; Associate Medical Director, North Carolina Baptist AirCare; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Tom Scaletta, MD, Past-President, American Academy of Emergency Medicine; Chairperson, Department of Emergency Medicine, Edward Hospital; Assistant Professor of Emergency Medicine, Rush Medical College and Cook County Hospital; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital Author and Editor Disclosure Synonyms and related keywords: acromioclavicular injury, acromioclavicular joint separation, acromioclavicular joint, AC, ACJ, acromioclavicular joint injuries, AC joint injuries, ACJ injuries, clavicular displacement, pediatric AC joint injury, shoulder injury, shoulder dislocation, clavicle dislocation, clavicular injury INTRODUCTIONBackgroundAcromioclavicular (AC) joint injuries most commonly occur in active or athletic young adults. Although uncommon, pediatric AC injuries are increasing because of the rising popularity of dangerous summer and winter sporting activities. PathophysiologyThe AC joint is composed of the articular surfaces of the clavicle and the acromion, a surrounding capsule, and 2 sets of ligaments (AC and coracoclavicular [CC] ligaments). The AC ligament is composed of stronger superior and inferior ligaments as well as weaker anterior and posterior ligaments. The AC ligament is the principle restraint to anteroposterior translation between the clavicle and the acromion. The CC ligament is composed of the conoid and trapezoid ligaments, which together form a strong, heavy band that provides vertical stability. The AC joint has minimal mobility. Classification of injury The degree of clavicular displacement depends on the severity of injury to the AC and CC ligaments, the AC joint capsule, and the supporting muscles of the shoulder (trapezius and deltoid) that attach to the clavicle. Allman and Tossy initially proposed a 3-grade classification that Rockwood expanded to 6 types of injury. Grades I and II are the same in both classification schemes with grade III injuries in the Tossy classification subdivided into grades III, IV, V, and VI in the Rockwood classification. The Rockwood classification is as follows:
Pediatric AC injury AC joint injuries in children are uncommon, and they differ anatomically from such injuries in adults. The immature clavicle is encased in a periosteal tube. The CC ligament is within this tissue, while the AC ligament is exterior to it. This anatomic relationship explains why the AC ligament is frequently injured with direct trauma, while the CC ligament remains intact. When evaluating a pediatric radiography, remember that incomplete closure of or failure of an ossification center may appear to be a fracture. The pediatric Rockwood classification is as follows:
FrequencyUnited StatesThe true incidence of AC injury is not known, as many affected do not seek treatment. Approximately 12% of all dislocations involving the shoulder affect the AC joint. Mortality/MorbidityMortality is not commonly associated with AC injuries. Significant morbidity is negligible with type I and II injuries. Types IV, V, and VI do well with surgical repair. Morbidity is highest with type III injuries due to the controversy surrounding management. RaceNo difference in injury patterns exists among various racial or ethnic backgrounds. SexMales sustain significantly more AC injuries due to larger participation in high-risk activities. AgeYounger patients (<35 y) sustain more AC injuries due to higher participation in risky activities. CLINICALHistoryAC injury often involves a fall onto the apex of the shoulder, usually with the arm in adduction. Severe forces resulting from significant falls are often associated with type III-VI injuries. Patients usually present with pain at the top of the shoulder at the acromioclavicular joint and can often be seen carrying the affected arm close to the side of their bodies. Alternatively, patients use the unaffected arm to splint the injured extremity. Abrasions and ecchymoses are common at the site of impact. PhysicalWhile examining the stability of the affected shoulder, the midshaft of the clavicle should be manipulated rather than the AC joint itself. The patient should be asked to place the hand of the affected side on the opposite shoulder while the examiner applies downward force on the affected elbow, trying to elicit pain at the AC joint. Patients may also experience pain upon direct palpation of the AC joint. Several techniques to directly assess the AC joint are discussed in the orthopaedic literature, although none of these maneuvers has been shown to have a high sensitivity or specificity. Palpating the bony structures of the shoulder for any stepoff that might suggest occult fracture as well as noting any displacement of the clavicle are important. A thorough neurovascular examination to rule out brachial plexus injury is also essential, although concomitant neurovascular injury is relatively rare in AC joint injuries. CausesDownward blunt force on the acromion results in variable injury to the AC and CC ligaments. Other injuries, depending on the force of injury, may include tears of the deltoid and trapezius attachments at the clavicle and fractures of the acromion, clavicle, and coracoid (or of their cartilaginous attachments). Athletes participating in contact sports, such as football and martial arts, are at increased risk of AC joint injuries. Patients involved in motor vehicle collisions with direct trauma to the apex of the shoulder are also at risk for AC injuries. DIFFERENTIALSRotator Cuff Injuries
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Ibuprofen (Motrin, Nuprin, Midol, Advil) |
|---|---|
| Description | In the absence of contraindications, usually DOC for treatment of mild to moderate pain. |
| Adult Dose | 200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d |
| Pediatric Dose | <6 months: Not established 6 months to 12 years: 20-40 mg/kg/d PO divided tid/qid >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus |
| Precautions | Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
These agents are used for mild-to-moderate analgesic effects.
| Drug Name | Acetaminophen (Tylenol, Aspirin Free Anacin) |
|---|---|
| Description | DOC for pain in patients with documented hypersensitivity to aspirin or NSAIDs, in those diagnosed with upper GI disease, or in those taking PO anticoagulants. |
| Adult Dose | 325-650 mg PO q4-6h or 1000 mg PO q6-8h; not to exceed 4 g/d |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d >12 years: 325-650 mg PO q4h; not to exceed 5 doses/d |
| Contraindications | Documented hypersensitivity; G-6-PD deficiency |
| Interactions | Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Hepatotoxicity possible in persons with chronic alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products and combined use with these products may result in cumulative acetaminophen doses exceeding recommended maximum dose |
These agents are used for moderate-to-strong analgesic effects.
| Drug Name | Propoxyphene and acetaminophen (Darvocet N-100) |
|---|---|
| Description | Indicated for the treatment of mild to moderate pain. |
| Adult Dose | 1-2 tab PO q4h prn; not to exceed 600 mg/d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase serum concentrations of MAOIs, TCAs, carbamazepine, phenobarbital, and warfarin |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Caution in patients dependent on opiates (substitution may result in acute opiate withdrawal symptoms); caution in severe renal or hepatic dysfunction |
| Drug Name | Hydrocodone bitartrate and acetaminophen (Vicodin ES) |
|---|---|
| Description | Indicated for the relief of moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn for pain |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose acetaminophen PO q4-6h prn; not to exceed 2.6 g/d of acetaminophen >12 years: 750 mg acetaminophen PO q4h; not to exceed 10 mg of hydrocodone bitartrate per dose; not to exceed 5 doses/d |
| Contraindications | Documented hypersensitivity; HACE; elevated ICP |
| Interactions | Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or TCAs |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Tabs contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates, since this substitution may result in acute opiate withdrawal symptoms; caution in severe renal or hepatic dysfunction |
| Drug Name | Acetaminophen and codeine (Tylenol with Codeine) |
|---|---|
| Description | Indicated for the treatment of mild to moderate pain. |
| Adult Dose | 30-60 mg/dose based on codeine content PO q4-6h or 1-2 tab PO q4h; not to exceed 12 tab/d |
| Pediatric Dose | 0.5-1 mg/kg/dose based on codeine PO q4-6h; 10-15 mg/kg/dose based on acetaminophen content; not to exceed 2.6 g/d of acetaminophen |
| Contraindications | Documented hypersensitivity |
| Interactions | Toxicity increases with CNS depressants or TCAs |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Caution in patients dependent on opiates, since this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction |
These agents have both anti-inflammatory and salt retaining properties. Glucocorticoids have profound and varied metabolic effects. In addition these agents modify the body's immune response to diverse stimuli.
| Drug Name | Triamcinolone hexacetonide (Aristospan, Kenalog) |
|---|---|
| Description | For inflammatory dermatosis responsive to steroids. Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. |
| Adult Dose | 20-40 mg injected into AC joint |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; fungal, viral, and bacterial skin infections |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Most common side effect is postinjection flare, which manifests as pain at injection site and can be relieved with oral NSAIDs; this pain is due to crystal deposition of the steroid preparation in the joint space and usually lasts <24 h Other side effects related to poor technique and include skin atrophy, hypopigmentation, and tendon rupture; rare side effects include infection of joint space and anaphylaxis; side effects such as Cushing syndrome, osteoporosis, and menstrual irregularities are rare and only occur when multiple injections are given over a relatively short time period A percentage of injected drug might be absorbed systemically; if application is repeated, some systemic effects of the corticosteroids may occur; most common side effect is postinjection flare due to crystal deposition of steroid preparation in joint space (lasts <24 h; can be relieved with oral NSAIDs); other side effects are related to poor technique and include skin atrophy, hypopigmentation, and tendon rupture May cause transient hyperglycemia in diabetics |
| Drug Name | Methylprednisolone (Depo-Medrol, Solu-Medrol) |
|---|---|
| Description | Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability. |
| Adult Dose | 30-40 mg intra-articular injection |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; viral, fungal or tubercular skin infections |
| Interactions | Coadministration with digoxin may increase digitalis toxicity secondary to hypokalemia; estrogens may increase levels of methylprednisolone; phenobarbital, phenytoin, and rifampin may decrease levels of methylprednisolone (adjust dose); monitor patients for hypokalemia when taking medication concurrently with diuretics; grapefruit juice increases prednisolone concentrations; methylprednisolone and cyclosporine mutually inhibit one another resulting in increased plasma levels of each drug |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Most common side effect is postinjection flare, which manifests as pain at injection site and can be relieved with oral NSAIDs; this pain is due to crystal deposition of the steroid preparation in joint space and usually lasts <24 h Other side effects are related to poor technique and include skin atrophy, hypopigmentation, and tendon rupture rare side effects include infection of joint space and anaphylaxis; side effects such as Cushing syndrome, osteoporosis, and menstrual irregularities are rare and only occur when multiple injections are given over a relatively short time period A percentage of injected drug might be absorbed systemically; if application is repeated, some systemic effects of the corticosteroids may occur; most common side effect is postinjection flare due to crystal deposition of steroid preparation in joint space (lasts <24 h; can be relieved with oral NSAIDs); other side effects are related to poor technique and include skin atrophy, hypopigmentation, and tendon rupture |
The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Cappi Lay, MD, to the development and writing of this article.
| Media file 1: Anteroposterior (AP) radiograph of right shoulder showing step-off of acromioclavicular (AC) joint. | |
![]() | View Full Size Image | Media type: X-RAY |
Acromioclavicular Injury excerpt
Article Last Updated: Apr 1, 2008